Overview
Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe
Status:
Completed
Completed
Trial end date:
2014-03-01
2014-03-01
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
The purpose of this study is to compare the pharmacokinetics of NVP-1205 and coadministration of rosuvastatin and ezetimibe.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Navipharm CorporationTreatments:
Ezetimibe
Rosuvastatin Calcium
Criteria
Inclusion Criteria:- Healthy male subjects age between 19 and 55 signed informed consent
Exclusion Criteria:
- subjects have a history of allergy reaction of this drug or other drugs